Core Insights - Tilray Brands, Inc. (TLRY) is set to report its second-quarter fiscal 2026 results on January 8, 2026, with revenue expectations of $209.7 million, reflecting a 0.6% decline year-over-year, and a consensus loss estimate of 14 cents per share, an improvement from a loss of $1 in the same quarter last year [1][2] Financial Performance - The company achieved a 100% earnings surprise in the last reported quarter but has an average negative earnings surprise of 8.3% over the trailing four quarters [2] Key Factors Impacting Performance - The upcoming quarterly performance may reveal weaknesses, including margin pressures in core segments due to a higher mix of lower-margin cannabis products and ongoing challenges in the beverage business [3][9] - The beverage segment is experiencing softness due to SKU rationalization, but the company is focused on turnaround strategies, including beer integration and Project 420 [4][9] - Strength in the Wellness business, supported by a robust product portfolio and expansion efforts, is expected to provide some cushion to the overall performance [5][9] Earnings Prediction Model - The current model does not predict an earnings beat for Tilray Brands, as it has an Earnings ESP of 0.00% and a Zacks Rank of 3, indicating a neutral outlook [6]

Industry Overview - The cannabis industry is evolving with renewed optimism as investors look toward 2026, with Canadian companies at the forefront of global expansion due to strong medical programs and increasing international demand [1][2] - Investors face challenges such as volatility, regulation, and changing consumer trends [1] Company Summaries Tilray Brands Inc. (TLRY) - Tilray is one of the largest cannabis and consumer wellness companies in Canada, operating in Canada, Europe, Latin America, and emerging medical markets [2] - The company does not own U.S. cannabis dispensaries but partners with licensed distributors, allowing for brand expansion while remaining compliant [2] - Recent financial performance shows gradual improvement, with revenue growth from both cannabis and beverage operations, although profitability remains challenging due to operating expenses and restructuring costs [4] - Investors are optimistic about potential catalysts such as expanding international medical programs and regulatory changes, but the stock may experience price swings [4] Cronos Group Inc. (CRON) - Cronos is a global cannabis and cannabinoid company focused on developing branded products for adult-use and medical markets, emphasizing quality and innovation [6] - The company collaborates with licensed partners instead of owning U.S. dispensaries, allowing for cautious growth while remaining compliant [6] - Financially, Cronos has reported steady revenue growth supported by strong demand for premium products, maintaining a solid balance sheet and improving gross margins [8] - Despite periodic net losses, the company's disciplined approach to growth appeals to investors seeking stability [8] Aurora Cannabis Inc. (ACB) - Aurora is a recognized cannabis producer in Canada, heavily involved in medical cannabis across multiple regulated markets [9] - The company focuses on export partnerships and compliant product channels instead of operating U.S. dispensaries [9] - Aurora's financial performance reflects a strategic shift toward profitability, with improved gross margins and reduced operating expenses [11] - The company has achieved positive adjusted earnings recently, indicating operational progress, and is expected to continue growth in international medical markets [11]

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is redefining what it means to drink mindfully with a collection that blends craft, creativity, and functionality. From hemp-derived delta-9 THC cocktails to zero-proof spirits and non-alcoholic beers, Tilray is making moderation feel indulgent, not limiting. As the sober curious movement gains mo ...

Artit Wongpradu / Shutterstock.com I recently saw a social media post which stood out to me. This post was a long-term chart going back about 50 years, highlighting all the downturns over this time frame, and all the reasons investors had to sell at particular down points in the market. Quick Read Curaleaf is down over 66% all-time as the cannabis sector has collapsed over the past five years. The iShares Bitcoin Trust ETF has declined nearly 30% from its late-2025 peak. Lululemon lost more than 40 ...

The Best Marijuana Stocks Under 10$ In 2026This week could be a big trading week for marijuana stocks to kick off 2026. At this time, there is a lot of speculation on what is next to come. These thoughts have been had for a long time, while most legal operators have been working in a grey area. Now that cannabis is considered a less harmful substance in the eyes of the government, more progress can be made. Not just that, for most marijuana stock investors, there is a safer roadmap towards profitability.Wit ...

Core Viewpoint - Simply Solventless Concentrates Ltd. (SSC) has appointed Charles Vennat to its board of directors, enhancing its leadership with significant experience in the cannabis and consumer packaged goods sectors [1][3]. Group 1: Appointment Details - Charles Vennat is an accomplished CEO with a background in leading complex manufacturing and regulated cannabis businesses [1][2]. - He has previously held senior leadership roles at 48North, Greentone Enterprises, and Bastos of Canada, providing him with deep expertise in the cannabis industry [2]. - Concurrent with his appointment, SSC granted Vennat 500,000 stock options at an exercise price of $0.15, with a vesting schedule over three years [3]. Group 2: Company Overview - Simply Solventless Concentrates Ltd. is a public company incorporated under the Business Corporations Act (Alberta) [4]. - The company's mission is to provide pure, potent, terpene-rich ready-to-consume cannabis products to discerning consumers [4].

Core Insights - Tilray Brands, Inc. is promoting cannabis-infused beverages as a mindful alternative during Dry January, emphasizing flavor and cannabinoid consistency [1][2] - The non-alcoholic beverage market in Canada has seen a significant growth of 24% year-over-year, reaching a total of $199 million, indicating a rising consumer preference for alcohol-free options [2] Product Offerings - Mollo and XMG are the two main brands under Tilray's campaign, offering a variety of cannabis-infused beverages that cater to different tastes and occasions [1][2] - Mollo Seltzer includes flavors like Blackberry, Wild Berry Açaí, Lemon, Mango, and Watermelon Lime, each containing 10 mg THC and 20 mg CBG per can [6][15] - XMG offers products such as Cream Soda Zero, Grape Ape Soda, and Tropical Cream Float, featuring 10 mg THC and varying CBG content, with some options being sugar-free [10][11][16] Market Positioning - The campaign positions cannabis beverages as a leading innovation within the non-alcoholic movement, appealing to adults looking for flavorful and mindful drinking options [2] - Tilray aims to elevate consumer experiences through its diverse product range, which includes over 40 brands across more than 20 countries, focusing on wellness and lifestyle [18]

Group 1 - The 420 Investor service, focused on cannabis stocks, was launched in 2013 and has now moved to Seeking Alpha, continuing to provide extensive coverage of the sector [1] - Alan Brochstein, a prominent figure in cannabis investment, has been involved in the financial industry since 1986 and founded AB Analytical Services in 2007 to offer independent consulting [1] - The 420 Investor group covers 20 cannabis stocks, providing investment news, earnings report previews, and post-report analyses, along with a model portfolio and multiple weekly video analyses [1]

Core Viewpoint - Planet 13 Holdings Inc. has granted 9,500,000 Restricted Stock Units (RSUs) to its officers, directors, and employees as part of its 2023 Equity Compensation Plan, which aims to enhance employee retention and align interests with shareholders [2]. Company Overview - Planet 13 is a vertically integrated cannabis company with operations in Nevada, Illinois, and Florida, known for its award-winning cultivation, production, and dispensary operations [3]. - The company operates the largest dispensary in the U.S., located in Las Vegas, and has recently opened its first consumption lounge, DAZED!, along with its first dispensary in Illinois [3]. - Planet 13's mission is to establish a globally recognized brand known for high-quality dispensary operations and innovative cannabis products [3]. - While cannabis activities are legal in the states where Planet 13 operates, they remain illegal under U.S. federal law [3]. Equity Compensation Plan - The 2023 Equity Compensation Plan, approved by shareholders, includes the awarding of RSUs that will vest in three equal tranches: upon grant, on May 16, 2026, and on May 16, 2027 [2].

Market Performance - The Dow Jones Industrial Average rose 0.7% in December, marking its eighth consecutive winning month, the longest streak since 2018 [1] - The S&P 500 slipped about 0.06% for the month, while the Nasdaq Composite finished down about 1% [1] - The final five trading sessions of December were downbeat, with the Nasdaq losing 1.3%, the S&P 500 retreating 0.9%, and the Dow Jones falling 0.7% [2] Seasonal Trends - Historically, stocks tend to rise during the final five trading days of the year and the first two sessions of the new year, a pattern now under threat [3] S&P 500 Performance - The S&P 500 rallied 24% in 2023, 23% in 2024, and 16% in 2025, resulting in an almost 80% gain over three years, marking the strongest return over a three-year win streak since 2019-2021 [4] - The S&P 500 has not posted four consecutive annual gains since the five-year run from 2003 to 2007 [5] Economic Indicators - The Federal Reserve has issued hawkish guidance for 2026, with a cooling U.S. labor market and persistent inflation [5] - The net impact of Trump tariffs remains unclear, and developed-market central banks are unlikely to cut rates at the beginning of 2026 [5] Sector Performance - Cannabis ETFs saw significant gains, with AdvisorShares Pure US Cannabis ETF (MSOS) up 35.6% and Roundhill Cannabis ETF (WEED) up 35.5% due to potential easing of federal marijuana regulations [7][8] - Silver ETFs also performed well, with abrdn Physical Silver Shares ETF (SIVR) up 25.9% and iShares Silver Trust (SLV) up 25.8%, driven by supply tightness and industrial demand [7][9] - Platinum ETFs, such as abrdn Physical Platinum Shares ETF (PPLT), rose 22.2% due to supply constraints and increased industrial usage [10] - Space ETFs, including Procure Space ETF (UFO), increased by 16.2%, bolstered by Rocket Lab's stock surge and positive developments in the space economy [11] - Copper Mining ETFs, like Global X Copper Miners ETF (COPX), rose 14.3% as copper prices hit records due to high demand and fragile supply, particularly from AI data centers [12]